IONIS PHARMACEUTICALS INC - NOTE 4/0

Historical Holders from Q2 2022 to Q3 2025

Type / Class
Debt / NOTE 4/0
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
603,281,000
Holdings value
$742,167,044
% of all portfolios
0%
Number of holders
27
Number of buys
10
Number of sells
-15
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 4/0

Period Principal Value Change Price Investors
2025 Q3 603,281,000 $742,167,044 +$66,516,809 $1.23 27
2025 Q2 549,711,910 $555,202,909 +$4,434,347 $1.01 33
2025 Q1 546,181,909 $539,251,665 -$12,257,592 $0.9843 34
2024 Q4 561,167,910 $543,386,109 +$17,580,583 $0.9668 47
2024 Q3 542,279,000 $542,911,225 -$45,379,695 $0.9973 56
2024 Q2 589,177,000 $608,248,104 +$385,167 $1.03 55
2024 Q1 590,897,000 $584,045,653 +$1,082,227 $0.9869 58
2023 Q4 585,686,397 $618,187,865 +$11,483,733 $1.05 53
2023 Q3 567,259,143 $556,222,929 -$25,001,583 $0.9788 52
2023 Q2 581,292,500 $550,280,148 +$51,108,656 $0.947 49
2023 Q1 537,145,000 $490,429,590 -$12,588,564 $0.9118 43
2022 Q4 557,303,500 $517,088,656 +$3,664,278 $0.9279 43
2022 Q3 485,742,000 $484,656,098 -$20,915,463 $0.9938 40
2022 Q2 505,668,900 $464,773,416 +$464,773,417 $0.9126 34